Answers are grounded in this paper and cite their sources.
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a struggle; however, treatment statistics have begun showing favorable results similar to those of younger DLBCL patients thanks to newer treatment protocols. Here, we analyze the progress of our own elderly DLBCL patients who were followed between 2000 and 2016 in our center.
No takes yet. Share an insight, caveat, or question.
Adıyaman et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: